ClinicalTrials.gov
public full text
Public Domain
Application of hUC-MSCs in Treating Acute Lung Injury: a Single Center Prospective Clinical Research
The patients suffered from acute lung ininjury (200\<PaO2/FiO2 ≤ 300) will be divided into two groups: MSCs-treated group: patients are treated by intravenous injection of hUC-MSCs suspention ; control group: patients were treated with vehicle(Albumin) . The standard Therapies of acute lung injury were the same in both groups. In the following-up days, all the patients were monitored by the same items to evaluate the therapeutic effects.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Role of Circulating Soluble CD74 in Acute Lung Injury#1030211
- Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell Therapy#847741
- Inflammation Severity and miRNA-126 in Trauma#804864
- A Combination of an Inhaled Budesonide and Ipratropium in Patients at Risk of Developing ARDS#917975
- Safety, PK and PD Relationships of RLS-0071 in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease#1009249
Record · ID 836402
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive